Mechanisms of repair after kidney injury

Journal of Nephrology

Volumn 16, Issue 2, 2003, Pages 186-195

  Menè, Paolo ^a   Polci, Rosaria ^a   Festuccia, Francescaromana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cell proliferation; Dedifferentiation; DNA damage; Kidney repair; Renal injury; Stem cells; Transdifferentiation

Indexed keywords

CHEMOKINE; CYTOKINE; DECORIN; DNA POLYMERASE; GENE PRODUCT; IMMUNOSUPPRESSIVE AGENT; MATRIX METALLOPROTEINASE; NUCLEOTIDE; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; THIAZIDE DIURETIC AGENT; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; APOPTOSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL INFILTRATION; CELL LOSS; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CHEMICAL INJURY; CHRONIC GRAFT REJECTION; CLEAR CELL CARCINOMA; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; GENE MUTATION; GENE THERAPY; GLOMERULUS BASEMENT MEMBRANE; HEALING; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIA; KIDNEY CARCINOMA; KIDNEY CELL; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY STRUCTURE; KIDNEY TRANSPLANTATION; LEUKOCYTE; NEPHRON; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; REVIEW; SEQUENCE ALIGNMENT; STEM CELL; TISSUE REPAIR; ACUTE KIDNEY FAILURE; ADAPTATION; CELL DIVISION; FEMALE; INJURY; KIDNEY; KIDNEY TUBULE NECROSIS; MALE; PHYSIOLOGY; REGENERATION; SENSITIVITY AND SPECIFICITY;

ADAPTATION, PHYSIOLOGICAL; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; DNA DAMAGE; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; REGENERATION; SENSITIVITY AND SPECIFICITY;

EID: 0043022151     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Anderson S, Tank JE, Brenner BM. Renal and systemic manifestations of glomerular disease. In Brenner and Rector's Ed. The Kidney; (6th edn). Philadelphia: WB Saunders 2000; 1871-900.
2. Cattel V, Jennette JC. Mechanisms of acute inflammatory and immunologic renal injury. In Jennette JC, Olson JL, Schwartz MM, Silva FG, Eds. Heptinstall's Pathology of the Kidney (5th edn). Philadelphia: Lippincott Williams & Wilkins 1998: 85-136.
3. Taal MW, Brenner BM. Evolving strategies for renoprotection: Non-diabetic chronic renal disease. Curr Opin Nephrol Hypertens 2001; 10: 523-31.
4. Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002; 136: 604-15.
5. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69-75.
6. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002; 23: 687-96.
7. Eickbush TH. Repair by retrotransposition. Nat Genet 2002; 31: 126-7.
8. Kashtan CE. Familial hematuric syndromes-Alport syndrome, thin glomerular basement membrane disease and Fechtner/Epstein syndromes. Contrib Nephrol 2001; 136: 79-99.
9. Torres VE, King BF, McKusick MA, Bjornsson J, Zincke H. Update on tuberous sclerosis complex. Contrib Nephrol 2001; 136: 33-49.
10. Qian Q, Harris PC, Torres VE. Treatment prospects for autosomal-dominant polycystic kidney disease. Kidney Int 2001; 59: 2005-22.
11. Godley PA, Taylor M. Renal cell carcinoma. Curr Opin Oncol 2001; 13: 199-203.
12. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000; 407: 784-8.
13. Orlov SN, Tremblay J, Deblois D, Hamet P. Genetics of programmed cell death and proliferation. Semin Nephrol 2002; 22: 161-171.
14. Soto H, Mosquera J, Rodriguez-Iturbe B, Henriquez La Roche C, Pinto A. Apoptosis in proliferative glomerulonephritis: Decreased apoptosis expression in lupus nephritis. Nephrol Dial Transplant 1997; 12: 273-80.
15. Tax WJ, Kramers C, Van Bruggen MC, Berden JH. Apoptosis, nucleosomes, and nephritis in lupus erythematosus. Kidney Int 1995; 48: 666-73.
16. Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, Skill NJ, Haylor JL, El Nahas AM. Expression of apoptosis-related genes and proteins in experimental chronic renal scarring. J Am Soc Nephrol 2001; 12: 275-88.
17. Ecder T, Melnikov VY, Stanley M, Korular D, Lucia MS, Schrier RW, Edelstein CL. Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int 2002; 61: 1220-30.
18. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-60.
19. Shevelev IV, Hubscher U. The 3′ 5′ exonucleases. Nat Rev Mol Cell Biol 2002; 3: 364-76.
20. Menè P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989; 69: 1347-424.
21. Rupprecht HD, Sterzel RB. Glomerular mesangial cells. In Neilson EG, Couser WG, Eds. Immunologic Renal Diseases. Philadelphia: Lippincott-Raven 1997; 595-626.
22. Mosley K, Collar J, Cattell V. Mesangial cell necrosis in Thy 1 glomerulonephritis - An ultrastructural study. Virchows Arch 2000; 436: 567-73.
23. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson R, Savill J. Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994; 94: 2105-16.
24. Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, El Nahas AM. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J Am Soc Nephrol 2001; 12: 485-95.
25. Al-Awqati Q, Oliver JA. Stem cells in the kidney. Kidney Int 2002; 6: 387-95.
26. Matsumoto K, Nakamura T. Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases. Kidney Int 2001; 59: 2023-38.
27. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001; 159: 1465-75.
28. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002; 13: 96-107.
29. Zeisberg M, Strutz F, Müller GA. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 2000; 13 (suppl 3): S111-20.
30. Okada H, Inoue T, Suzuki H, Strutz F, Neilson EG. Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. Nephrol Dial Transplant 2000; 15 (suppl 6): S44-6.
31. Strutz F, Müller GA. Transdifferentiation comes of age. Nephrol Dial Transplant 2000; 15: 1729-31.
32. Kim Y-G, Suga S-I, Kang D-H, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 2000; 58: 2390-99.
33. Suga S, Kim YG, Joly A, Puchacz E, Kang DH, Jefferson JA, Abraham JA, Hughes J, Johnson RJ, Schreiner GF. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int 2001; 60: 1297-308.
34. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001; 159: 599-608.
35. Yokoi H, Mukoyama M, Sugawara A, Mori K, Nagae T, Makino H, Suganami T, Yahata K, Fujinaga Y, Tanaka I, Nakao K. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 2002; 282: F933-42.
36. Gaedeke J, Peters H, Noble NA, Border WA. Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol 2001; 135: 153-60.
37. Inkinen K, Soots A, Krogerus L, Lindroos P, Bruggeman C, Ahonen J, Lautenschlager I. Cytomegalovirus infection enhances connective tissue growth factor mRNA expression in a rat model of chronic renal allograft rejection. Transplant Proc 2001; 33: 379.
38. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002; 13: (suppl 1): S14-21.
39. Gould SE, Day M, Jones SS, Dorai H. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 2002; 61: 51-60.
40. Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 2002; 13: 411-22.
41. Ito T, Suzuki A, Imai F, Okabe M, Hori M. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodelling. J Am Soc Nephrol 2001; 12: 2625-35.
42. Ito T, Suzuki A, Okabe M, Imai E, Hori M. Application of bone marrow-derived stem cells in experimental nephrology. Exp Nephrol 2001; 9: 444-50.
43. Imasawa T, Utsunomiya Y, Kawamura T, Zhong Y, Nagasawa R, Okabe M, Maruyama N, Hosoya T, Ohno T. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 2001; 12: 1401-09.
44. Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, McKenna RM, Stern E, Rush DN. Neointimal and tubulo-interstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 2001; 345: 93-7.
45. Poulsom R, Forbes SJ, Hodivala-Dilke K, Ryan E, Wyles S, Navaratnarash S, Jeffery R, Hunt T, Alison M, Cook T, Pusey C, Wright NA. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001; 195: 229-35.
46. Sainio K, Raatikainen-Ahokas A. Mesonephric kidney - A stem cell factory? Int J Dev Biol 1999; 43: 435-9.
47. Schedl A, Hastie ND. Cross-talk in kidney development. Curr Opin Genet Dev 2000; 10: 543-9.
48. Kashgarian M. Acute tubular necrosis and ischemic renal injury. In Jenette JC, Olson JL, Schwartz MM, Silva FG Eds. Heptinstall's Pathology of the Kidney (5th edn). Philadelphia: Lippincott Williams & Wilkins 1998; 863-90.
49. Stuart RO, Bush KT, Nigam SK. Changes in global gene expression patterns during development and maturation of the rat kidney. Proc Natl Acad Sci USA 2001; 98: 5649-54.
50. Kitamura M, Fine LG. Gene transfer into the adult kidney for unravelling disease processes. Exp Nephrol 1998; 6: 429-37.
51. Tomasoni S, Remuzzi G, Benigni A. Gene therapy to the kidney. Contrib Nephrol 2001; 136: 140-56.